The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-[[4-(2-chlorophenyl)piperazin-1-yl]methyl]-1-methyl-5-(4-phenylpiperazine-1-carbonyl)pyrrole-2-carbonitrile ID: ALA5220604
PubChem CID: 134515401
Max Phase: Preclinical
Molecular Formula: C28H31ClN6O
Molecular Weight: 503.05
Associated Items:
Names and Identifiers Canonical SMILES: Cn1c(C(=O)N2CCN(c3ccccc3)CC2)cc(CN2CCN(c3ccccc3Cl)CC2)c1C#N
Standard InChI: InChI=1S/C28H31ClN6O/c1-31-26(28(36)35-17-15-33(16-18-35)23-7-3-2-4-8-23)19-22(27(31)20-30)21-32-11-13-34(14-12-32)25-10-6-5-9-24(25)29/h2-10,19H,11-18,21H2,1H3
Standard InChI Key: YBVDOWOAPVPVJA-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
-0.2986 -1.5802 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9660 -1.0953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7111 -0.3105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1139 -0.3105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3688 -1.0953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2986 -2.4054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1659 -1.3089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5265 0.4040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3517 0.4040 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7643 1.1187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5895 1.1187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0021 0.4040 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5895 -0.3105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7643 -0.3105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8273 0.4040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2401 1.1186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0629 1.1178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4756 0.4030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0664 -0.3088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2416 -0.3137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8291 -1.0283 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.7631 -1.3089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9767 -2.1059 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3466 -0.7254 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.1437 -0.9390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7272 -0.3554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5137 0.4416 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.7166 0.6551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1330 0.0716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0972 1.0251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9630 -1.5224 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.8944 0.8117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4756 1.3940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2619 2.1913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4692 2.4054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8826 1.8256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
1 6 1 0
5 7 1 0
4 8 1 0
8 9 1 0
10 9 1 0
11 10 1 0
12 11 1 0
13 12 1 0
14 13 1 0
9 14 1 0
12 15 1 0
16 15 2 0
17 16 1 0
18 17 2 0
19 18 1 0
20 19 2 0
15 20 1 0
20 21 1 0
2 22 1 0
22 23 2 0
22 24 1 0
25 24 1 0
26 25 1 0
27 26 1 0
28 27 1 0
29 28 1 0
24 29 1 0
27 30 1 0
7 31 3 0
32 30 2 0
33 32 1 0
34 33 2 0
35 34 1 0
36 35 2 0
30 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 503.05Molecular Weight (Monoisotopic): 502.2248AlogP: 3.83#Rotatable Bonds: 5Polar Surface Area: 58.75Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 5.14CX LogP: 4.29CX LogD: 4.29Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.53Np Likeness Score: -1.63
References 1. Oleksak P, Nepovimova E, Chrienova Z, Musilek K, Patocka J, Kuca K.. (2022) Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021)., 238 [PMID:35688004 ] [10.1016/j.ejmech.2022.114498 ]